Endologix

Irvine, United States Founded: 1992 • Age: 34 yrs Listed
Minimally invasive treatments for aortic disorders are developed and manufactured.

About Endologix

Endologix is a company based in Irvine (United States) founded in 1992. Endologix has completed 2 acquisitions, including Nellix and PQ Bypass. Endologix offers products and services including DETOUR System, EVAR Portfolio, ALTO, and AFX2. Endologix operates in a competitive market with competitors including Endoron Medical, Trivascular, Altura Medical, Aptus Endosystems and Remon Medical, among others.

Key Metrics
  • Latest Funding Round
    $52.2M (USD), Debt – Conventional

    Apr 2019

  • Investors
    Deerfield

    & 1 more

  • Investments & Acquisitions
    Nellix

    & 1 more

Products & Services of Endologix

Endologix offers a comprehensive portfolio of products and services, including DETOUR System, EVAR Portfolio, ALTO, and AFX2.

DETOUR System
Medical Device

Treats peripheral artery disease with minimally invasive interventions.

EVAR Portfolio
Endovascular Solutions

Provides treatments for aortic aneurysms and vascular conditions.

ALTO
Medical Device

Offers advanced solutions for endovascular aneurysm repair.

AFX2
Medical Device

Supports endovascular procedures for vascular health.

Apps and channels of Endologix

its YouTube channel Endologix LLC has 792 subscribers and 26 videos.

Endologix LLC
YouTube 792 subscribers 26 videos Science & Technology
Open channel

Videos from Endologix

The most watched videos on Endologix's YouTube channel, Endologix LLC (792 subscribers). Click a video to play it here.

PTAB using the DETOUR System Procedure Animation_MM2589 US Rev 03
53.7K views
ALTO Deployment Animation MM 2200 Rev 02
21.3K views
DETOUR System Overview
4.3K views
VR for EVAR
2.1K views

More on Endologix LLC.

Funding Insights of Endologix

  • Total Rounds 5
  • Last Round Debt – Conventional β€” $52.2M
  • First Round $15M

    (Oct 2010)

  • Investors Count 2

All 5 funding rounds of Endologix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2019$52.2MDebt – Conventional––
–
Aug 2018$210.5MPost-IPO––
–
Apr 2017$179.72MDebt – Conventional––
Jul 2016$50MDebt – Conventional––
–
Oct 2010$15MPost-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in Endologix

Endologix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Deerfield and EW Healthcare Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Healthcare ecosystem is supported through investment and innovation by Deerfield.
–deerfield.comNew York, United States
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
–ewhealthcare.comNew York, United States
Premium access

Investor details for Endologix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Endologix

19 people are tracked at Endologix (10 in leadership, 7 in board & advisors, 2 in team).

NameRoleGroup
Chip Richter
VP, Health Economics & ReimbursementLeadership
Cindy Pinto
Chief Financial OfficerLeadership
William Willis
VP, QualityLeadership
Matt Thompson
President & CEOLeadership
Matt Poole
VP, EngineeringLeadership
Beth Rothwell
Chief Operating OfficerLeadership
Sandy Prietto
Senior Director & Head of MarketingLeadership
Wesley Wallace
Senior Director, Supply Chain & LogisticsLeadership
Pamela Mann
Director,global Training And ServicesLeadership
Genevieve Dunbar
VP, Regulatory AffairsLeadership
Taylor Harris
DirectorBoard & advisors
Bryan Sendrowski
DirectorBoard & advisors
Abraham Kometz
DirectorBoard & advisors
Andrew Elbardissi
DirectorBoard & advisors
Sumner Anderson
DirectorBoard & advisors
Richard Mott
Executive ChairmanBoard & advisors
Lucas Buchanan
DirectorBoard & advisors
Collene Hoaglin
AccountantTeam
Diane Diaz
Principal Engineer TechnicianTeam
Premium access

Complete people profiles for Endologix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Endologix

Endologix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nellix and PQ Bypass.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Percutaneous approach for femoral artery bypass
pqbypass.comMountain View, United States2011Apr 2021β€’β€’β€’β€’
Medical device catering less invasive treatment of Abdominal Aortic Aneurysms
nellix.comPalo Alto, United States1994Oct 2010β€’β€’β€’β€’
Premium access

Complete acquisition details for Endologix

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Endologix

6 dated milestones of Endologix across 29 years, from founding to its latest funding, stage changes and deals.

  1. Founded Endologix is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $15.0M.
  4. Acquisition Acquires Nellix.
  5. Funding Latest funding round, Debt – Conventional, of $52.2M.
  6. Acquisition Acquires PQ Bypass.

Competitors of Endologix

Endologix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endoron Medical, Trivascular, Altura Medical, Aptus Endosystems and Remon Medical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
endoronmedical.com2019Kfar Saba, Israel$15M–
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
trivascular.com1998Santa Rosa, United States$260.95M307
Designs and manufactures for endovascular aortic repair equipment
alturamedical.com2008Menlo Park, United States$49.5M–
Endovascular devices for aortic aneurysms are developed.
aptusendo.com2002Sunnyvale, United States$70M63
Endograft anchoring systems for aortic aneurysms are developed.
remonmedical.com1997Caesarea, Israel$26M–
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
endovastec.com2012Shanghai, China––
Medical devices for treating aortic diseases are developed.
nellix.com1994Palo Alto, United States$18.2M–
Medical device catering less invasive treatment of Abdominal Aortic Aneurysms
medeonbio.com2012Taipei, Taiwan––
Minimally invasive devices for cardiovascular and laparoscopic procedures are developed.
jotec.com2000Hechingen, Germany–451
Stents and Grafts for Aortic and Peripheral arterial disease
Premium access

Detailed competitors of Endologix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Endologix

The website of Endologix (endologix.com) receives about 5.4K visits a month.

  • Monthly visits
    5.4K

    ▲ 37.9% vs previous month

Similar websites

Websites whose visitors overlap most with Endologix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medtronic.com
100%
2.6M#22,622View details
cookmedical.com
99%
–#429,169View details
arrowintl.com
82%
––View details
bardpv.com
82%
1.4K#13,184,975View details
moh.gov.om
moh.gov.om
77%
–#46,885–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Endologix

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Endologix

Premium access

Complete news archive for Endologix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Endologix

10 companies that operate in the same segment as Endologix (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
SMT is recognized as a developer of cardiovascular medical devices.
1998Surat, Gujarat, IndiaUSD 57.22 MUSD 106.25 M1,090
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M–255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
2006San Francisco, California, United StatesUSD 109.23 MUSD 747.14 M2,000
Provider of neuroprotection devices for carotid artery disease
2007Sunnyvale, California, United StatesUSD 241.8 M––
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
2007East Peoria, Illinois, United StatesUSD 154.77 M–104
Access catheters for neurovascular stroke treatment are provided.
2015Campbell, California, United StatesUSD 596 M––
Biosensor patches are developed for monitoring multiple body vitals.
2011Campbell, California, United StatesUSD 239.95 M–184
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Endologix

Endologix was founded in 1992 and raised its 1st funding round 18 years after it was founded.

Endologix is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologixs flagship product is the Powerlink System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. It acquired Nellix, a developer of medical devices for the minimally invasive treatment of aortic aneurysms.

Endologix's top competitors include Trivascular, Shanghai MicroPort Endovascular MedTech and Jotec.

Endologix offers DETOUR System, EVAR Portfolio, ALTO, and AFX2.

Endologix has made 2 acquisitions, including Nellix, and PQ Bypass.

Endologix has 2 investors. Key investors include Deerfield, and EW Healthcare Partners.

Endologix operates through Endologix Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available